April 23rd 2025
For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Advocate Speaks on Critical Research Needs in Hidradenitis Suppurativa
August 20th 2022Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with hidradenitis suppurativa (HS), spoke on key areas of HS comprehension and management that warrant further investigation in clinical research.
Watch
Drug Survival of Dupilumab Affected by Immunosuppressive Therapy, Older Age in AD
August 18th 2022Investigator Global Assessment score of very severe atopic dermatitis (AD) was associated with dupilumab discontinuation due to adverse effects, although generally adequate 1-, 2-, and 3-year drug survival rates were also observed.
Read More
Kidney Function Linked With Parkinson Disease Risk in Patients With T2D
August 16th 2022Korean patients with type 2 diabetes (T2D) who had reduced levels of estimated glomerular filtration rate and/or proteinuria, 2 hallmarks of diabetic kidney disease, had a greater risk of developing Parkinson disease.
Read More
Advocate Speaks on Prior Authorization, Insurance-Related Barriers for HS Treatment
August 13th 2022Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with hidradenitis suppurativa (HS), discussed step edits and other barriers to treatment caused by insurance requirements in the management of HS.
Watch
Whether Hospital Care at Home Continues When Pandemic Emergency Ends Is Up to Congress
August 12th 2022When the pandemic public health emergency eventually ends, so will the various waivers and regulatory flexibilities enacted by HHS during the COVID-19 pandemic, including the ability to provide acute hospital care at home, unless Congress acts.
Read More
Disease Burden of Alopecia Areata Greater in Lower-Income Countries
August 11th 2022Despite decreasing trends observed in the global burden of alopecia areata, low-income countries and Western Sub-Saharan Africa regions continue to exhibit rising incidence and disability-adjusted life-years rates.
Read More
Hepatitis C Reinfection Rates Low After Successful Treatment in People Who Inject Drugs
August 8th 2022Treatment of hepatitis C virus (HCV) with direct-acting antiviral medications was associated with low HCV reinfection rates among patients who inject drugs, although risk for reinfection was highest in the first 24 weeks of treatment and among those with ongoing injecting drug use.
Read More
Advocate Addresses Factors Physicians Should Consider in Managing Hidradenitis Suppurativa
August 5th 2022Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with hidradenitis suppurativa (HS), spoke on the need for awareness among physicians and patients on the clinical features of HS in regard to both physical and psychosocial burdens.
Watch
Advocate Discusses Her Family's History With Hidradenitis Suppurativa
July 30th 2022The journey to a diagnosis of hidradenitis suppurativa was different for her compared with the path faced by her children, said Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with the disease.
Watch
Overuse of Systemic Corticosteroids, Substantial Cost Burden for AD Seen in Germany
July 29th 2022Systemic corticosteroids were more commonly prescribed vs other systemic drug options in Germany for patients with atopic dermatitis (AD) despite their unfavorable risk-benefit profile, with a substantial economic burden cited among these populations.
Read More
Registries Highlight the Needs of Patients With COPD in Primary Care
July 28th 2022US patients with chronic obstructive pulmonary disease (COPD) managed in primary care settings have high exacerbations, symptoms, and treatment burdens, according to an analysis of electronic health record data and patient-reported information/outcomes.
Read More
Senator Joe Manchin, D-West Virginia, ended his opposition to the Inflation Reduction Act of 2022, paving the way for reductions in some Affordable Care Act subsidies and action on drug pricing; AbbVie’s Allergan agreed to pay more than $2 billion in opioid settlements; a study found vitamin D supplements do not reduce bone fracture risk.
Read More
Bacteria Behind Rare Disease Melioidosis Found in US for First Time
July 27th 2022For the first time, the CDC has identified in Mississippi dirt and water samples a bacteria that causes a rare and sometimes fatal disease called melioidosis, which is common in low-income tropical countries and one that scientists have been warning about for several years.
Read More
US Monkeypox Cases Number Nearly 3600 as HHS Approves Additional Vaccine
July 27th 2022The number of monkeypox cases in the United States is close to 3600, the CDC said this week, and on Wednesday, HHS approved a supplement to the biologics license for a vaccine made by Bavarian Nordic to prevent smallpox and monkeypox.
Read More
Contributor: How Medication Risk Scores Improve Health for Medicare Beneficiaries
July 27th 2022Medication risk scores analyze an individual’s medication regimen to look for the potential for simultaneous, multi-drug interactions, which can cause adverse drug events and other medication-related harms.
Read More
Risk of Myocardial Infarction Greater Among Patients With Hidradenitis Suppurativa
July 25th 2022An increased risk of developing myocardial infarction was observed among patients with hidradenitis suppurativa (HS), whereas risk of cerebrovascular accident and peripheral vascular disease was comparable between those with HS and controls.
Read More